HETERODIMERE PROTEINE

European patent · EP3936521 · In force

Register entry

Publication number
EP3936521
Application number
EP21173787
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 17, 2014
Published
Jan 12, 2022
Granted
Feb 11, 2026
Protection ends at the latest
Mar 16, 2034
Next annual fee due
Mar 31, 2027
IPC classes
C07K 16/00 (2006.01)
C07K 16/06 (2006.01)
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
Priority
US 201361794896 P 15.03.2013
US 201361818401 P 01.05.2013
US 201361818153 P 01.05.2013
US 201361818344 P 01.05.2013
US 201361913832 P 09.12.2013
US 201361913879 P 09.12.2013
US 201361913870 P 09.12.2013
US 201414155334 14.01.2014
WO PCT/US2014/011549 14.01.2014
US 201461938095 P 10.02.2014
US 201414205248 11.03.2014
US 201414207489 12.03.2014
Divided from
EP19175124
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 12, 2026

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 12.05.2026

  2. Apr 27, 2026

    Change

    Published in Swissreg on 27.04.2026

  3. Feb 11, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.02.2026

Parties

Holder

Xencor, Inc.

465 North Halstead Street Suite 200, Pasadena, CA 91107, US

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

MOORE, Gregory

Monrovia, 91016, US

DESJARLAIS, John

Monrovia, 91016, US

RASHID, Rumana

Monrovia, 91016, US

BERNETT, Matthew J.

Monrovia, 91016, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.